Rudy Li
Stock Analyst at Chardan Capital
(4.90)
# 53
Out of 5,134 analysts
28
Total ratings
75%
Success rate
105.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $30 | $24.98 | +20.10% | 4 | Jan 2, 2026 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $83.91 | -4.66% | 3 | Jan 2, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $80 → $330 | $328.04 | +0.60% | 3 | Oct 17, 2025 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $41.60 | +32.21% | 4 | Oct 7, 2025 | |
| IMUX Immunic | Initiates: Buy | $3 | $0.92 | +227.05% | 1 | Sep 29, 2025 | |
| ANRO Alto Neuroscience | Initiates: Buy | $15 | $19.26 | -22.12% | 1 | Sep 29, 2025 | |
| RVPH Reviva Pharmaceuticals Holdings | Initiates: Buy | $2 | $0.26 | +656.72% | 1 | Sep 29, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $18 | $8.96 | +100.89% | 7 | Aug 28, 2025 | |
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $31.11 | -22.85% | 4 | Aug 13, 2025 |
Centessa Pharmaceuticals
Jan 2, 2026
Maintains: Buy
Price Target: $30
Current: $24.98
Upside: +20.10%
Bright Minds Biosciences
Jan 2, 2026
Maintains: Buy
Price Target: $80
Current: $83.91
Upside: -4.66%
Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $80 → $330
Current: $328.04
Upside: +0.60%
Xenon Pharmaceuticals
Oct 7, 2025
Maintains: Buy
Price Target: $55
Current: $41.60
Upside: +32.21%
Immunic
Sep 29, 2025
Initiates: Buy
Price Target: $3
Current: $0.92
Upside: +227.05%
Alto Neuroscience
Sep 29, 2025
Initiates: Buy
Price Target: $15
Current: $19.26
Upside: -22.12%
Reviva Pharmaceuticals Holdings
Sep 29, 2025
Initiates: Buy
Price Target: $2
Current: $0.26
Upside: +656.72%
Prothena Corporation
Aug 28, 2025
Maintains: Buy
Price Target: $18
Current: $8.96
Upside: +100.89%
Stoke Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $24
Current: $31.11
Upside: -22.85%